Agree completely with viewson massive resource &potential to expand dramatically, uranium potential not recognised by market,tight capital structure, and perhaps of equal importance Board/ management. Gordon Toll is a company maker - consider his ability to structure placement to 2 U.S. funds & HNC deal.- brilliant. Additional points to consider/remember. 1 JORC Mt.Fitch Uranium expected within 2 weeks. 2 FIRB approval for HNC deal expected within 2 weeks 3 Who is beneficial owner Merrill Lynch holding ?? If a potential predator, surely only chance of successful bid would be prior to issue of shares to Guardain ( Josh Pitt) and HNC. With tight share register would need significant premium to succeed - no chance once Chinese & Guardian issues made. 4 Gurdian ( Josh Pitt ) Huge seal of approval to CMR that Josh Pitt elected to take shares in consideration for Guardian's 10%. One of Aust's most astute investors could have elected cash - tells you something !! 5 Market activity for past 2 weeks gives me impression of deliberate capping (fore- runner to a bid ?? )
Summary: A must for all portfolios, grossly undervalued on NPV & future earnings & resource upgrades + ditinct possibility of short term corporate action (for which they'd have to pay top dallar to succeed )
CMR Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held